UnitedHealth Group to Discuss 2017 Financial Outlook at Investor Conference

UBS Raises Price Target on UnitedHealth Group (UNH) Following Investor Day

UBS reiterated a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $193.00 (from $180.00), following the company's investor day. UNH expects its Medicare Advantage enrollment to grow by 700-800K lives in 2017, a 19-22% Y/Y increase. UBS raised 2016 EPS estimates to $9.45 and... More

Leerink Partners Raises Price Target on UnitedHealth Group (UNH) to $195; Reiterates Outperform

Leerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $195.00 (from $185.00), following a company update. EPS guidance of $9.30 - $9.60 came in better than the Street expectation of $9.16. The EPS upside is driven by better than expected top-line growth in MA, and Optum as well as the ObamaCare tax holiday.

Analyst Ana Gupte, commented, "We remain bullish on UNH (OP) and reiterate our top pick status on the name while raising estimates and PT to $195. In addition to surprising meaningfully to the upside on 2017 guidance,... More

Mizuho Securities Upgrades UnitedHealth Group (UNH) to Buy

Mizuho Securities upgraded UnitedHealth Group (NYSE: UNH) from Neutral to Buy with a price target of $178.00.

Analyst Sheryl Skolnick commented, "Despite the still-uncertain politics of health care, we are raising our rating on UNH shares to Buy/$178 PT. UNH made a compelling... More

Jefferies Remains Bullish on UnitedHealth Group (UNH) Following Conference Call

Jefferies reiterated a Buy rating and $168.00 price target on UnitedHealth Group (NYSE: UNH) following the company's 3Q earnings conference call.

Analyst David Windley commented, "CEO Hemsley's supportive comments of 2017 consensus on the 3Q16 earnings call foreshadowed a positive outlook. Considering that... More